Loading
Loading
Organ & Bioregulator Research · 20mg
Janoshik-tested · 10 vials per kit
Thymogen is a synthetic dipeptide bioregulator studied in preclinical research for its immune-modulating properties. Research has examined its potential to stimulate T-lymphocyte activity, enhance phagocytic and cytotoxic activity in macrophages and natural killer cells, and promote secretion of immune cytokines including interleukin-2. Studies have explored applications in immunocompromised populations, infectious disease support, and immune disorder models.
≥98%
Purity
Lyophilised
Format
2–3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock — weekday same/next-day delivery available.
Chemical Properties
Need to work out your dose?
Use our reconstitution calculator — syringe units in seconds.
Research Use Only — Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
Thymogen
Glu-Trp (Oglufanide)
Thymogen is a synthetic dipeptide (glutamyl-tryptophan, Glu-Trp) known internationally as Oglufanide. One of the shortest thymic peptides with documented immunological activity in the Khavinson bioregulator series, it has been studied for its role in T-lymphocyte regulation and used clinically in Russia.
Thymogen is studied for modulation of T-lymphocyte maturation and proliferation, effects on IL-2 secretion from T-helper cells, and stimulation of thymic stromal cell activity. As with other Khavinson dipeptides, chromatin-level interaction in thymic and lymphoid precursor cells is proposed as the underlying regulatory mechanism.
Preclinical and Russian clinical studies describe improvement in immune parameters in patients with secondary immunodeficiency, respiratory infections, and post-surgical immune suppression. Thymogen has been studied as an intranasal immunomodulator for respiratory conditions. Its small size and stability make it of interest for bioavailability research in oral and mucosal delivery systems.
For research reference only. All information pertains to preclinical or published human trial data. Not intended as medical advice. This product is for research use only.
Don't have supplies? Grab them while you're here.
